Breast Cancer After Treatment of Hodgkin's Lymphoma: General Review

      The improved survival rates among patients with Hodgkin's lymphoma over the past few decades have come with increased incidence of second malignancies. One of the major concerns among female survivors is the significantly elevated risk of breast cancer that appears with extended follow-up. In this review, we include the published literature regarding the risk of breast cancer after irradiation for Hodgkin's lymphoma. We also present the possible long-term surveillance strategies and the optimal time to start screening these women. This could potentially help in early detection of secondary breast cancers and consequently improve outcomes. Furthermore, because of prior radiotherapy, the management of the breast cancer among this unique population has been controversial. We discuss the characteristics of breast cancer that occurs after Hodgkin's lymphoma and also treatment options that could be implemented.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hodgkin T.
        On some morbid appearances of the absorbent glands and spleen.
        Medico-Chirugical Trans. 1832; 17: 68-114
        • Harris N.L.
        • Jaffe E.S.
        • Diebold J.
        • et al.
        World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997.
        J Clin Oncol. 1999; 17: 3835-3849
        • Boivin J.F.
        • O'Brien K.
        Solid cancer risk after treatment of Hodgkin's disease.
        Cancer. 1988; 61: 2541-2546
        • Kaldor J.M.
        • Day N.E.
        • Band P.
        • et al.
        Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries.
        Int J Cancer. 1987; 39: 571-585
        • Tucker M.A.
        • Coleman C.N.
        • Cox R.S.
        • et al.
        Risk of second cancers after treatment for Hodgkin's disease.
        N Engl J Med. 1988; 318: 76-81
        • Wahner-Roedler D.L.
        • Nelson D.F.
        • Croghan I.T.
        • et al.
        Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.
        Mayo Clin Proc. 2003; 78: 708-715
        • Devita Jr., V.T.
        • Serpick A.A.
        • Carbone P.P.
        Combination chemotherapy in the treatment of advanced Hodgkin's disease.
        Ann Intern Med. 1970; 73: 881-895
        • Bonadonna G.
        • Zucali R.
        • Monfardini S.
        • et al.
        Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
        Cancer. 1975; 36: 252-259
        • Wirth A.
        • Corry J.
        • Laidlaw C.
        • et al.
        Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
        Int J Radiat Oncol Biol Phys. 1997; 39: 599-607
        • Somers R.
        • Carde P.
        • Henry-Amar M.
        • et al.
        A randomized study in Stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: A European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
        J Clin Oncol. 1994; 12: 279-287
        • Meyer R.M.
        Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?.
        Eur J Haematol Suppl. 2005; : 115-120
        • Kaplan H.
        Hodgkin's disease. Vol 2.
        Harvard University Press, Cambridge, MA1980
        • Meyer R.M.
        • Gospodarowicz M.K.
        • Connors J.M.
        • et al.
        Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
        J Clin Oncol. 2005; 23: 4634-4642
        • Diehl V.
        Hodgkin's disease—from pathology specimen to cure.
        N Engl J Med. 2007; 357: 1968-1971
        • Cheson B.D.
        • Pfistner B.
        • Juweid M.E.
        • et al.
        Revised response criteria for malignant lymphoma.
        J Clin Oncol. 2007; 25: 579-586
        • Diehl V.
        • Franklin J.
        • Pfreundschuh M.
        • et al.
        Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
        N Engl J Med. 2003; 348: 2386-2395
        • Raemaekers J.
        • Burgers M.
        • Henry-Amar M.
        • et al.
        Patients with Stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: Interim results from the ongoing EORTC-LCG and GPMC Phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
        Ann Oncol. 1997; 8: 111-114
        • Aleman B.M.
        • Raemaekers J.M.
        • Tirelli U.
        • et al.
        Involved-field radiotherapy for advanced Hodgkin's lymphoma.
        N Engl J Med. 2003; 348: 2396-2406
        • Hancock S.L.
        • Tucker M.A.
        • Hoppe R.T.
        Breast cancer after treatment of Hodgkin's disease.
        J Natl Cancer Inst. 1993; 85: 25-31
        • Bhatia S.
        • Robison L.L.
        • Oberlin O.
        • et al.
        Breast cancer and other second neoplasms after childhood Hodgkin's disease.
        N Engl J Med. 1996; 334: 745-751
        • Sankila R.
        • Garwicz S.
        • Olsen J.H.
        • et al.
        Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.
        J Clin Oncol. 1996; 14: 1442-1446
        • Tinger A.
        • Wasserman T.H.
        • Klein E.E.
        • et al.
        The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique.
        Int J Radiat Oncol Biol Phys. 1997; 37: 865-870
        • van Leeuwen F.E.
        • Klokman W.J.
        • Hagenbeek A.
        • et al.
        Second cancer risk following Hodgkin's disease: A 20-year follow-up study.
        J Clin Oncol. 1994; 12: 312-325
        • Wolden S.L.
        • Lamborn K.R.
        • Cleary S.F.
        • et al.
        Second cancers following pediatric Hodgkin's disease.
        J Clin Oncol. 1998; 16: 536-544
        • Gervais-Fagnou D.D.
        • Girouard C.
        • Laperriere N.
        • et al.
        Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease.
        Oncology. 1999; 57: 224-231
        • Alm El-Din M.A.
        • Hughes K.S.
        • Finkelstein D.M.
        • et al.
        Breast cancer after treatment of hodgkin's lymphoma: Risk factors that really matter. In press.
        Int J Radiat Oncol Biol Phys. 2008;
        • Metayer C.
        • Lynch C.F.
        • Clarke E.A.
        • et al.
        Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
        J Clin Oncol. 2000; 18: 2435-2443
        • Ng A.K.
        • Bernardo M.V.
        • Weller E.
        • et al.
        Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors.
        Blood. 2002; 100: 1989-1996
        • Travis L.B.
        • Curtis R.E.
        • Boice Jr., J.D.
        Late effects of treatment for childhood Hodgkin's disease.
        N Engl J Med. 1996; 335: 352-353
        • Travis L.B.
        • Hill D.
        • Dores G.M.
        • et al.
        Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
        J Natl Cancer Inst. 2005; 97: 1428-1437
        • van Leeuwen F.E.
        • Klokman W.J.
        • Veer M.B.
        • et al.
        Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
        J Clin Oncol. 2000; 18: 487-497
        • Kaldor J.M.
        • Day N.E.
        • Clarke E.A.
        • et al.
        Leukemia following Hodgkin's disease.
        N Engl J Med. 1990; 322: 7-13
        • Travis L.B.
        • Hill D.A.
        • Dores G.M.
        • et al.
        Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
        JAMA. 2003; 290: 465-475
        • Baral N.E.
        • Larsson L.E.
        • Mattsson B.
        Breast cancer following irradiation of the breast.
        Cancer. 1977; 40: 2905-2910
        • Boice Jr., J.D.
        Radiation and breast carcinogenesis.
        Med Pediatr Oncol. 2001; 36: 508-513
        • Boice Jr., J.D.
        • Preston D.
        • Davis F.G.
        • et al.
        Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts.
        Radiat Res. 1991; 125: 214-222
        • Hildreth N.G.
        • Shore R.E.
        • Dvoretsky P.M.
        The risk of breast cancer after irradiation of the thymus in infancy.
        N Engl J Med. 1989; 321: 1281-1284
        • Little M.P.
        • Boice Jr., J.D.
        Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors.
        Radiat Res. 1999; 151: 218-224
        • Mattsson A.
        • Ruden B.I.
        • Hall P.
        • et al.
        Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease.
        J Natl Cancer Inst. 1993; 85: 1679-1685
        • Preston D.L.
        • Mattsson A.
        • Holmberg E.
        • et al.
        Radiation effects on breast cancer risk: A pooled analysis of eight cohorts.
        Radiat Res. 2002; 158: 220-235
        • Zellmer D.L.
        • Wilson J.F.
        • Janjan N.A.
        Dosimetry of the breast for determining carcinogenic risk in mantle irradiation.
        Int J Radiat Oncol Biol Phys. 1991; 21: 1343-1351
        • van Leeuwen F.E.
        • Klokman W.J.
        • Stovall M.
        • et al.
        Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
        J Natl Cancer Inst. 2003; 95: 971-980
        • Koh E.S.
        • Tran T.H.
        • Heydarian M.
        • et al.
        A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: Reduction in normal tissue dose and second cancer risk.
        Radiat Oncol. 2007; 2: 13
        • Salloum E.
        • Doria R.
        • Schubert W.
        • et al.
        Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
        J Clin Oncol. 1996; 14: 2435-2443
        • Chung C.T.
        • Bogart J.A.
        • Adams J.F.
        • et al.
        Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease.
        Int J Radiat Oncol Biol Phys. 1997; 37: 405-409
        • Dietrich P.Y.
        • Henry-Amar M.
        • Cosset J.M.
        • et al.
        Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen?.
        Blood. 1994; 84: 1209-1215
      1. Alm El-Din MA, Hughes KS, Abi Raad R, et al. Breast cancer occurring after treatment for Hodgkin's lymphoma: Case-control analysis. Submitted for publication.

        • Dershaw D.D.
        • Yahalom J.
        • Petrek J.A.
        Breast carcinoma in women previously treated for Hodgkin disease: Mammographic evaluation.
        Radiology. 1992; 184: 421-423
        • Wolden S.L.
        • Hancock S.L.
        • Carlson R.W.
        • et al.
        Management of breast cancer after Hodgkin's disease.
        J Clin Oncol. 2000; 18: 765-772
        • Yahalom J.
        • Petrek J.A.
        • Biddinger P.W.
        • et al.
        Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients.
        J Clin Oncol. 1992; 10: 1674-1681
        • Cutuli B.
        • Dhermain F.
        • Borel C.
        • et al.
        Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients.
        Eur J Cancer. 1997; 33: 2315-2320
        • Tokunaga M.
        • Land C.E.
        • Tokuoka S.
        • et al.
        Incidence of female breast cancer among atomic bomb survivors, 1950–1985.
        Radiat Res. 1994; 138: 209-223
        • Nyandoto P.
        • Muhonen T.
        • Joensuu H.
        Second cancer among long-term survivors from Hodgkin's disease.
        Int J Radiat Oncol Biol Phys. 1998; 42: 373-378
      2. National Cancer Institute. Surveillance Epidemiology and End Results. SEARCH Cancer Statistics review. Available at: Accessed October 16, 2008.

        • Heron D.E.
        • Komarnicky L.T.
        • Hyslop T.
        • et al.
        Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
        Cancer. 2000; 88: 2739-2750
        • Hungness E.S.
        • Safa M.
        • Shaughnessy E.A.
        • et al.
        Bilateral synchronous breast cancer: Mode of detection and comparison of histologic features between the 2 breasts.
        Surgery. 2000; 128: 702-707
        • Janov A.J.
        • Tulecke M.
        • O'Neill A.
        • et al.
        Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study.
        Breast J. 2001; 7: 46-52
        • Mauch P.M.
        • Kalish L.A.
        • Marcus K.C.
        • et al.
        Second malignancies after treatment for laparotomy staged IA–IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome.
        Blood. 1996; 87: 3625-3632
        • Christie D.R.
        • Wills R.
        • Drew J.F.
        • et al.
        The doses received by the breast during mantle radiotherapy.
        Int J Radiat Oncol Biol Phys. 1998; 41: 223-226
        • Valagussa P.
        Second neoplasms following treatment of Hodgkin's disease.
        Curr Opin Oncol. 1993; 5: 805-811
        • Sanna G.
        • Lorizzo K.
        • Rotmensz N.
        • et al.
        Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
        Ann Oncol. 2007; 18: 288-292
        • Aref I.
        • Cross P.
        Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease.
        Br J Radiol. 2000; 73: 905-906
        • Deutsch M.
        • Gerszten K.
        • Bloomer W.D.
        • et al.
        Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma.
        Am J Clin Oncol. 2001; 24: 33-34
        • Intra M.
        • Gentilini O.
        • Veronesi P.
        • et al.
        A new option for early breast cancer patients previously irradiated for Hodgkin's disease: Intraoperative radiotherapy with electrons (ELIOT).
        Breast Cancer Res. 2005; 7: R828-R832
        • Alm El-Din M.A.
        • Feng J.K.
        • Taghian A.G.
        Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma.
        Nat Clin Pract Oncol. 2008; 5: 426-429
        • Diller L.
        • Medeiros Nancarrow C.
        • Shaffer K.
        • et al.
        Breast cancer screening in women previously treated for Hodgkin's disease: A prospective cohort study.
        J Clin Oncol. 2002; 20: 2085-2091
      3. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis Guidelines V.I. 2008. Available at: Accessed May 29, 2008.

        • Berg W.A.
        • Blume J.D.
        • Cormack J.B.
        • et al.
        Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
        JAMA. 2008; 299: 2151-2163
        • Saslow D.
        • Boetes C.
        • Burke W.
        • et al.
        American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
        CA Cancer J Clin. 2007; 57: 75-89
        • Aisenberg A.C.
        • Finkelstein D.M.
        • Doppke K.P.
        • et al.
        High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
        Cancer. 1997; 79: 1203-1210
        • Fisher B.
        • Costantino J.P.
        • Wickerham D.L.
        • et al.
        Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
        J Natl Cancer Inst. 1998; 90: 1371-1388


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.